CTLA4 promoter methylation predicts response and progression-free survival in stage IV melanoma treated with anti-CTLA-4 immunotherapy (ipilimumab)
| Image |  |
|---|---|
| Description | scientific article published on 16 November 2020 |
| Author/s |
author: Dimo Dietrich |
| Publication date | November 16, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |